To determine whether nucleolin protein expression levels are indicative of the state of HCC progression, we analyzed the association between nucleolin immunostaining scores and tumor stage, tumor grade, serum AFP level, presence of cirrhosis, underlying liver disease including alcohol abuse, viral hepatitis B and C, gender, and age. This evidence concerns the gene NUCLEOLIN and liver disorder.